Brief: Brainsway Announces Positive OCD Coverage Policy From Blue Cross Blue Shield (BCBS) Licensee Highmark BCBS For Deep TMS
21/06/2022 14:43
June 21 (Reuters) - Brainsway Ltd BWAY.TA :
* BRAINSWAY ANNOUNCES POSITIVE OCD COVERAGE POLICY FROM BLUE
CROSS
BLUE SHIELD® (BCBS) LICENSEE HIGHMARK BCBS FOR DEEP TMS™
Source text for Eikon: ID:nGNXc7QtX2
Further company coverage: BWAY.TA
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)